thymidine has been researched along with spironolactone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Calle, C; Campión, J; Carranza, MC; Dávila, N; Maestro, B; Molero, S | 1 |
| Arulmani, U; Chai, W; Danser, AH; Garrelds, IM; Lamers, JM; Schoemaker, RG | 1 |
2 other study(ies) available for thymidine and spironolactone
| Article | Year |
|---|---|
Aldosterone impairs insulin responsiveness in U-937 human promonocytic cells via the downregulation of its own receptor.
Topics: Aldosterone; Biological Transport; Dose-Response Relationship, Drug; Down-Regulation; Glucose; Humans; Insulin; Kinetics; Protein Binding; Receptor, Insulin; Receptors, Mineralocorticoid; RNA; RNA, Messenger; Spironolactone; Thymidine; Time Factors; U937 Cells | 2002 |
Genomic and nongenomic effects of aldosterone in the rat heart: why is spironolactone cardioprotective?
Topics: Aldosterone; Angiotensin II; Animals; Animals, Newborn; Blood Pressure; Cardiotonic Agents; Cells, Cultured; Collagen; Coronary Circulation; DNA; Fibroblasts; Heart; In Vitro Techniques; Male; Mineralocorticoid Receptor Antagonists; Myocardium; Rats; Rats, Wistar; Receptors, Mineralocorticoid; Spironolactone; Thymidine; Vasoconstrictor Agents; Ventricular Function, Left | 2005 |